Skip to content Skip to footer

USA Gears Towards Federal Cannabis Reform

USA Gears Towards Federal Cannabis Reform
Share this story
Share on twitter
Share on linkedin
Share on email

Alex Khourdaji – Analyst

February 5th, 2020


USA Gears Towards Federal Cannabis Reform

Therefore, it is expected that there is a clear path for major federal cannabis reform with many expecting the US to legalise cannabis in the next couple of years. The news from Georgia was also felt by the public markets cannabis stocks soared, with Tilray stocks increasing by 19.1% and Canopy Growth stocks reaching 17.7% at intraday highs.

The Georgia run-off election results come on the heels of the Democratic win for the White House and all cannabis ballot measures passing in Arizona, Mississippi, Montana, New Jersey and South Dakota. The overwhelming support for cannabis is not going unnoticed with lawmakers in New York and Connecticut proposing to legalise cannabis in their given states. The attitude towards cannabis is changing in the US, and many believe that we are at the tipping point of drastic federal change in the nation.

Alongside state-wide legalisation, on 4th December 2020 the House of Representatives passed the Marijuana Opportunity Reinvestment and Expungement Act (MORE ACT) of which Vice-President Kamala Harris is a lead sponsor. The MORE ACT is a bill that seeks to decriminalise cannabis federally and removes cannabis from the Controlled Substances Act. The bill is one of the most comprehensive cannabis decriminalisation bills to-date. It pursues to end the current war on cannabis, aid economic development and promote criminal justice reform. It is no surprise that the legislation passed through the democratic led House of Representatives as September 2020 poll by The Justice Collaborative Institute & Data For Progress suggested that the MORE Act had support from Democrat (70%) and Republican (53%) voters.

The MORE Act will significantly impact the cannabis industry as the de-scheduling of cannabis would ignite massive growth on a national level. The bill would promote the legal interstate trade of cannabis, permitting cannabis companies to expand into other regions in the US, which would fuel competition and growth in the industry. The legislation not only focuses on the long-awaited legalisation of cannabis but shines a light on the much-needed programmes needed to integrate communities, who have been affected by cannabis criminalisation, into the legal industry. The legislation implements a 5% excise tax on cannabis products to fund expungement efforts, in addition to the establishment of grant programmes to communities that have been affected by the war on drugs. Thus, it is essential to note that if this bill or a more advanced version of it passes the Senate, it will aid the US cannabis market and benefit those affected by its criminalisation.

For more information regarding the US and Canadian cannabis market please download Prohibition Partners North American Cannabis Report Here.

Prohibition Partners North American Report takes a deep dive on the current social, economic, regulatory and health trends including:

  • US 2020 Elections
  • The Rise of SPAC’s
  • The 2019/2020 Vaping Crises
  • Federal Cannabis Reform
  • Social Equity Programmes
  • Canada’s Cannabis 2.0 Roll-Out
  • COVID-19

The North American report also includes sales forecasts of medical and adult-use cannabis in the US and Canada.

Recent posts
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
April 14, 2022
One Step Forward for CBD in the UK, but Questions Remain at Home and Abroad

Catch up on our newest articles that you might have missed

Untitled design (11)
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
The relatively close integration of medical cannabis into the European healthcare systems has contributed to a patient population and purchasing...
il-vagabiondo-Q7QCj-9-q3I-unsplash
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
Underlining the cautious approach Europe is taking to the liberalisation of medical cannabis are the pilot trial access schemes for...
vincent-ghilione-z54zUmYA9f8-unsplash
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
Last week the first pilot project trial for the legalised sales of adult-use cannabis in Basel, Switzerland was approved by...
thomas-kelley--8iE9ykf3Us-unsplash
April 14, 2022
One Step Forward for CBD in the UK, but Questions Remain at Home and Abroad
The recent publishing of the list of CBD products with a valid Novel Foods application by the UK’s Food Safety...